Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation on chronic hemodialysis: a meta-analysis of randomized controlled trials
ConclusionIn this meta-analysis of three RCTs, no significant difference was observed between DOACs and VKAs in cardiovascular mortality, all-cause mortality, ischemic/uncertain type of stroke or transient ischemic attack, or major or life-threatening bleeding in patients with AF on chronic hemodialysis.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Databases & Libraries | Dialysis | Heart | Hemodialysis | Ischemic Stroke | Statistics | Stroke | Urology & Nephrology | Vitamin K | Vitamins